Walgreens Boots Alliance, Inc.’s Stock Price Plunges to $12.19, Marking a Sharp 22.16% Decline

Walgreens Boots Alliance, Inc. (WBA)

12.19 USD -3.47 (-22.16%) Volume: 132.44M

Walgreens Boots Alliance, Inc.’s stock price stands at 12.19 USD, witnessing a steep fall of -22.16% in the current trading session with a high trading volume of 132.44M, reflecting a significant YTD decrease of -53.31%, underlining a challenging period for WBA’s market performance.

Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance stock price took a hit after the company reported a massive earnings miss and slashed its profit guidance, leading to a 27-year low for its shares. The disappointing Q3 2024 earnings results prompted the CEO to announce plans to close a significant number of underperforming stores in the face of challenging consumer demand and a tough retail environment. Investors reacted to the news by selling off shares, causing the stock to plummet as the company grapples with reduced profit expectations and a focus on restructuring its physical footprint to adapt to changing market conditions.

Walgreens Boots Alliance, Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma have recently published two research reports on Walgreens Boots Alliance. The first report, titled “Walgreens Boots Alliance Inc.: Redefining Relationships & Creating Value with Payers! – Major Drivers,” highlights the company’s second-quarter operational results meeting expectations. The report emphasizes the solid performance in the U.S. Retail Pharmacy segment and internationally, resulting in an adjusted EPS of $1.20. Baptista Research evaluates various factors that could impact the company’s stock price in the near future using a Discounted Cash Flow methodology.

Another report by Baptista Research, titled “Walgreens Boots Alliance Inc.: The Health & Retail Revolution – Unveiling Their Path To Future Growth! – Major Drivers,” focuses on the company’s ability to surpass revenue and earnings expectations amidst challenges in the U.S. retail environment. The report acknowledges Walgreens’ resilience in executing cost discipline in the U.S. Retail Pharmacy segment, strong international performance, and progress in U.S. Healthcare profitability initiatives. Despite facing macroeconomic difficulties, Walgreens’ management is committed to strategic moves for future growth.

A look at Walgreens Boots Alliance, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Walgreens Boots Alliance has received a high score of 5 for its Dividend outlook, indicating a strong performance in this area. This suggests that the company has a solid track record of providing consistent and reliable dividends to its shareholders, making it an attractive option for investors looking for steady income.

However, the company’s Growth, Resilience, and Momentum scores are lower, at 2 each. This suggests that while Walgreens Boots Alliance may not be experiencing significant growth or momentum in the market, it still maintains a strong value proposition. With its diverse range of products and health services, the company continues to be a key player in the retail drugstore industry, offering a wide variety of goods and services to its customers.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma